Impact of hepatitis B virus co-infection on response to highly active antiretroviral treatment and outcome in HIV-infected individuals: A nationwide cohort study

HIV Medicine

Volumn 9, Issue 5, 2008, Pages 300-306

  Omland, L H ^a   Weis, N ^b   Skinhoj P ^a   Laursen, A L ^c   Christensen, P B ^d   Nielsen, H I ^e   Moller A ^f   Engsig, F ^a   Sorensen H T ^c,g   Obel, N ^a  

^a Rigshospitalet   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

^e AALBORG UNIVERSITY HOSPITAL   (Denmark)

^f KOLDING HOSPITAL   (Denmark)

^g BOSTON UNIVERSITY   (United States)

Author keywords

HBV; HIV; HIV HBVco infection

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; EFAVIRENZ; EMTRICITABINE; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TENOFOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CAUSE OF DEATH; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; DENMARK; DRUG RESPONSE; FEMALE; HEPATITIS B; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; VIRUS LOAD;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DRUG RESISTANCE, VIRAL; FEMALE; HEPATITIS B, CHRONIC; HIV INFECTIONS; HIV-1; HUMANS; LIVER DISEASES; MALE; PROSPECTIVE STUDIES; VIRAL LOAD;

EID: 42049098872     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2008.00564.x     Document Type: Article

References (14)

1. Lohse N, Hansen AB, Pedersen G et al. Survival of persons with and without HIV infection in Denmark, 1995-2005. Ann Intern Med 2007; 146: 87-95.
2. Konopnicki D, Mocroft A, de Wit S et al. Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA Cohort. AIDS 2005; 19: 593-601.
3. Law WP, Duncombe CJ, Mahanontharit A et al. Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT Cohort. AIDS 2004; 18: 1169-1177.
4. De Luca A, Bugarini R, Lepri AC et al. Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naïve HIV-infected subjects. Arch Intern Med 2002; 162: 2125-2132.
5. Lincoln D, Petoumenos K, Dore GJ. HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy. HIV Med 2003; 4: 241-249.
6. Osborn MK, Guest JL, Rimland D. Hepatitis B virus and HIV coinfection: relationship of different serological patterns to survival and liver disease. HIV Med 2007; 8: 271-279.
7. Thio CL, Seaberg EC, Skolasky R Jr et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 2002; 360: 1921-1926.
8. Lohse N, Hansen AB, Jensen-Fangel S et al. Demographics of HIV-1 infection in Denmark: Results from the Danish HIV Cohort Study. Scand J Infect Dis 2005; 37: 338-343.
9. Jensen-Fangel S, Pedersen L, Pedersen C et al. The effect of race/ ethnicity on the outcome of highly active antiretroviral therapy for human immunodeficiency virus type 1-infected patients. Clin Infect Dis 2002; 35: 1541-1548.
10. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health 1989; 79: 340-349.
11. Hoffmann CJ, Thio CL. Clinical implications of HIV and hepatitis B co-infection in Asia and Africa. Lancet Infect Dis 2007; 7: 402-409.
12. Weis N, Lindhardt BO, Kronborg G et al. Impact of hepatitis C virus coinfection on response to highly active antiretroviral therapy and outcome in HIV-infected individuals: A nationwide cohort study. Clin Infect Dis 2006; 42: 1481-1487.
13. Hatzakis A, Magiorkinis E, Haida C. HBV virological assessment. J Hepatol 2006; 44 (Suppl.): 71-76.
14. Hansen AB, Gerstoft J, Kronborg G, Pedersen C, Sorensen HT, Obel N. Mortality in siblings of patients coinfected with HIV and hepatitis C virus. J Infect Dis 2007; 195: 230-235.